Ziopharm Oncology
ZIOP
#8592
Rank
โ‚ฌ0.15 B
Marketcap
0,74ย โ‚ฌ
Share price
-0.88%
Change (1 day)
-77.76%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -โ‚ฌ75.26 Million

According to Ziopharm Oncology's latest financial reports the company's current earnings are โ‚ฌ3.73 Million. In 2020 the company made an earning of -โ‚ฌ68.19 Million a decrease over its 2019 earnings that were of -โ‚ฌ49.1 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚ฌ75.26 Million10.37%
2020-โ‚ฌ68.19 Million38.89%
2019-โ‚ฌ49.1 Million7.33%
2018-โ‚ฌ45.74 Million0.77%
2017-โ‚ฌ45.39 Million-67.64%
2016-โ‚ฌ0.15 Billion37.64%
2015-โ‚ฌ0.11 Billion176.1%
2014-โ‚ฌ36.91 Million-24.63%
2013-โ‚ฌ48.98 Million-43.51%
2012-โ‚ฌ86.7 Million43.09%
2011-โ‚ฌ60.59 Million190.88%
2010-โ‚ฌ20.83 Million102.46%
2009-โ‚ฌ10.29 Million-52.68%
2008-โ‚ฌ21.74 Million-10.33%
2007-โ‚ฌ24.25 Million15.35%
2006-โ‚ฌ21.02 Million355.36%
2005-โ‚ฌ4.62 Million13788.35%
2004-โ‚ฌ0.04 Million9.27%
2003-โ‚ฌ0.04 Million-10.26%
2002-โ‚ฌ0.04 Million-59.35%
2001-โ‚ฌ0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ6.99 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.81 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-โ‚ฌ2.34 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.23 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA